Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Chinese Medicine and Healthcare Products	1.56B
Chinese Medicine and Healthcare Products Growth	5.90%
Service	50.73M
Service Growth	0.08%
Royalty	151.00K
Royalty Growth	-65.60%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Hong Kong	1.07B
Hong Kong Growth	16.86%
Overseas	402.62M
Overseas Growth	-16.17%
China	139.37M
China Growth	7.76%